![PDF) Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial PDF) Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial](https://i1.rgstatic.net/publication/299577568_Acute_renal_effects_of_the_GLP-1_receptor_agonist_exenatide_in_overweight_type_2_diabetes_patients_a_randomised_double-blind_placebo-controlled_trial/links/5726f8ef08ae262228b2175b/largepreview.png)
PDF) Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
![WO2014134225A2 - Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance - Google Patents WO2014134225A2 - Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance - Google Patents](https://patentimages.storage.googleapis.com/91/83/5f/f75a6d878d4536/imgf000204_0001.png)
WO2014134225A2 - Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance - Google Patents
![WO2014134225A2 - Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance - Google Patents WO2014134225A2 - Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance - Google Patents](https://patentimages.storage.googleapis.com/8b/17/4f/cf23878db8ff5b/imgf000206_0001.png)
WO2014134225A2 - Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance - Google Patents
![WO2014134225A2 - Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance - Google Patents WO2014134225A2 - Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance - Google Patents](https://patentimages.storage.googleapis.com/d4/29/38/9e947da8fbebb5/imgf000175_0001.png)
WO2014134225A2 - Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance - Google Patents
![WO2014134225A2 - Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance - Google Patents WO2014134225A2 - Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance - Google Patents](https://patentimages.storage.googleapis.com/f8/bc/0b/4794bd95a56834/imgf000194_0001.png)
WO2014134225A2 - Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance - Google Patents
![PDF) Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial PDF) Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial](https://www.researchgate.net/profile/Marcel_Muskiet/publication/299577568/figure/fig2/AS:941370621566984@1601451654154/Flow-diagram-of-study-participants_Q320.jpg)
PDF) Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
![WO2014134225A2 - Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance - Google Patents WO2014134225A2 - Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance - Google Patents](https://patentimages.storage.googleapis.com/e2/61/4e/656d708668711e/imgf000152_0001.png)